India’s GLP-1 Market Faces New Hurdles After Record Growth
## Key Takeaways – India’s GLP-1 agonist market has surged to nearly Rs 2,000 crore, experiencing 237% growth in the past year. – Generic semaglutide versions by Indian manufacturers have significantly expanded access to these treatments. – Despite rapid expansion,…
